Blouet Clémence, Ono Hiraku, Schwartz Gary J
Diabetes Research and Training Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Cell Metab. 2008 Dec;8(6):459-67. doi: 10.1016/j.cmet.2008.10.004.
p70 S6 kinase 1 (S6K) is a major downstream effector of the mammalian target of rapamycin (mTOR), primarily implicated in the control of protein synthesis, cell growth, and proliferation. Here we demonstrate that specific bidirectional molecular targeting of mediobasal hypothalamic (MBH) S6K activity in rats is sufficient to significantly alter food intake, body weight, hypothalamic orexigenic neuropeptide expression, hypothalamic leptin sensitivity, and the metabolic and feeding responses to a fast. In addition, adenoviral-mediated constitutive activation of MBH S6K improved cold tolerance and protected against high-fat diet-induced overeating, fat deposition, and insulin resistance. Our results provide direct evidence that MBH S6K activity bidirectionally drives behavioral and metabolic determinants of energy balance and promote the assessment of MBH S6K activity as a therapeutic target in metabolic diseases.
p70核糖体蛋白S6激酶1(S6K)是哺乳动物雷帕霉素靶蛋白(mTOR)的主要下游效应器,主要参与蛋白质合成、细胞生长和增殖的调控。在此,我们证明,特异性双向分子靶向大鼠中脑基底部下丘脑(MBH)的S6K活性足以显著改变食物摄入量、体重、下丘脑促食欲神经肽表达、下丘脑瘦素敏感性以及禁食时的代谢和进食反应。此外,腺病毒介导的MBH S6K组成性激活改善了耐寒性,并预防了高脂饮食诱导的暴饮暴食、脂肪沉积和胰岛素抵抗。我们的结果提供了直接证据,表明MBH S6K活性双向驱动能量平衡的行为和代谢决定因素,并促进将MBH S6K活性评估为代谢疾病的治疗靶点。